NervGen Pharma Corp. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
Supporting Evidence:
The company stated in the following press release that they use animals for drug testing.
“The fact that NVG-291-R showed an effect in an animal model seven days after the onset of stroke is very encouraging,” stated Dr. S. Claiborne Johnston, a leading specialist in stroke care and research, formerly the inaugural Dean at Dell Medical School and now a professor in the Department of Neurology at Dell Medical School at The University of Texas at Austin.” Read the following article
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. NervGen Pharma Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Company Website: https://www.nervgen.com